Indoco Remedies Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹467.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.71 per cent from ₹475.61 crore. This corresponds to a year-on-year *(YoY) growth of 6.33 per cent.
Operating Profit
Operating Profit stands at ₹41.02 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.48 per cent from ₹49.71 crore. This corresponds to a year-on-year *(YoY) growth of 134.00 per cent.
PBDT
PBDT stands at ₹112.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,398.66 per cent from ₹7.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,712.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹77.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 410.88 per cent from ₹-25.00 crore. This corresponds to a year-on-year *(YoY) growth of 312.00 per cent.
Net Profit
Net Profit stands at ₹65.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 376.35 per cent from ₹-23.68 crore. This represents a 280.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | -0.46% | -0.32% | 6.49% | -3.70% | 22.79% | -15.29% |
| Venus Remedies | -0.55% | 1.33% | 7.31% | 4.16% | 81.91% | 295.41% |
| Syncom Formul. | 7.36% | 7.92% | 23.82% | 78.09% | 91.92% | 47.20% |
| Sai Parenteral's | -0.95% | 3.94% | -1.41% | -12.88% | 22.42% | 27.71% |
| Panacea Biotec | -1.42% | 2.19% | -9.32% | -35.73% | 10.85% | -18.42% |
| Windlas Biotech | -0.69% | 1.06% | -10.12% | 24.64% | 28.39% | 11.98% |
| NGL Fine Chem | -0.16% | 2.84% | 11.90% | -3.31% | 30.53% | 109.89% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN